Kurt Huber

Showing 1-13 of 13 articles

Coronary interventions

Culprit lesion location and outcomes in patients with multi-vessel disease and infarct-related cardiogenic shock. A core laboratory analysis of the CULPRIT-SHOCK trial

Hauguel-Moreau M, Barthelemy O, Farhan s, Huber K, Rouanet S, Zeitouni M, Guedeney P, Hage G, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G

September 8, 2020 | 10.4244/EIJ-D-20-00561

Coronary interventions

Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: A CULPRIT-SHOCK angiographic substudy

Overtchouk P, Barthelemy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet J, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G, Bertin B, Brugier D, Vignolles N, Hage G, El Kasty M, Kerneis M, Huber K, Sandri M, Noc M, Fuernau G

July 7, 2020 | 10.4244/EIJ-D-20-00139

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

Chieffo A, Stefanini G, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan G, Gilard M, Halvorsen S, Huber K, James S, Neumann F, Möllmann H, Roffi M, Tavazzi G, Mauri Ferre J, Windecker S, Dudek D, Baumbach A

June 25, 2020 | 10.4244/EIJY20M05_01

Coronary interventions

Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial

Fabris E, van’t Hof A, Hamm C, Lapostolle F, Lassen J, Goodman S, ten Berg J, Bolognese L, Cequier A, Chettibi M, Hammett C, Huber K, Janzon M, Merkely B, Storey R, Zeymer U, Cantor W, Rousseau H, Vicaut E, Montalescot G

May 15, 2017 | 10.4244/EIJ-D-16-00965

Coronary interventions

Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified

Huber K, Verheugt F

March 20, 2017 | 10.4244/EIJV12I16A315

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

Capodanno D, Lip G, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet J, Valgimigli M, Byrne R

January 22, 2015 | 10.4244/EIJV10I9A174

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force

Gorenek B, Blomström-Lundqvist C, Terradellas J, Camm A, Hindricks G, Huber K, Kirchhof P, Kuck K, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz R, Valgimigli M, Vos M, Vrints C, Zeymer U, Kristiansen S

January 22, 2015

An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents

Katsaros K, Kastl S, Krychtiuk K, Hutter R, Zorn G, Maurer G, Huber K, Wojta J, Christ G, Speidl W

June 20, 2014 | 10.4244/EIJV10I2A36

Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology

Hamon M, Pristipino C, Di Mario C, Nolan J, Ludwig J, Tubaro M, Sabaté M, Mauri Ferre J, Huber K, Niemela K, Haude M, Wijns W, Dudek D, Fajadet J, Kiemeneij F

March 22, 2013 | 10.4244/EIJV8I11A192

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update

Cuisset T, Valgimigli M, Mudra H, Mueller O, Wijns W, Huber K

May 25, 2010

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions

Cuisset T, Mudra H, Mueller O, Vogt P, Angelillo-Scherrer A, Huber K

August 20, 2008

Suessenbacher A, Doerler J, Alber H, Aichinger J, Altenberger J, Benzer W, Christ G, Globits S, Huber K, Karnik R, Norman G, Siostrzonek P, Zenker G, Pachinger O, Weidinger F

August 20, 2008

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers